Fentanyl Citrate Injection recalled over sterility concerns
- Recall date
- November 1, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Hospira Inc. recalls Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., Lake Forest IL…
- Recall number
- D-0153-2017
- FDA classification
- Class II
- Brand / firm
- Hospira Inc.
- Sold / distributed
- Nationwide
Why it was recalled
Lack of Assurance of Sterility: Complaints of broken tips on the ampules.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., Lake Forest IL 60045, NDC 0409-4093-32
Get recall alerts
Free email alert whenever Hospira Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hospira Inc.